Cell therapy for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests a new type of cell therapy called cfMSC for people with type 2 diabetes. The goal is to see if it can help control blood sugar better, possibly by helping the body use insulin more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and have had it for more than 3 years.
- Your blood sugar is not well controlled despite usual treatment, with an A1c of 7.5% or higher for 3 straight months.
- You are 18 to 75 years old and your weight is in a healthy range for your height (BMI 18.5–35).
- Your pancreas still makes some insulin (a blood test will check this).
- You are generally in good health, with no serious heart, kidney, liver, or other major organ problems, and no active infections or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental stem cell treatment (DT2-SCT) to see if it can improve blood sugar control in people with type 2 diabetes who need insulin. It is a double-blind study, so neither you nor the study team will know if you get the real treatment or a placebo.
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.
This trial tests using your own fat stem cells to help control blood sugar in type 2 diabetes. It might help if you have had diabetes for less than 10 years and are not on insulin.
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
This study tests a treatment that uses a patient's own immune cells to help the body make more insulin. It may help people with type 1 diabetes manage their blood sugar better.
Hear when a new Type II Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.